These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 8955659)
1. Prediction of colorectal cancer relapse and survival via tissue RNA levels of matrix metalloproteinase-9. Zeng ZS; Huang Y; Cohen AM; Guillem JG J Clin Oncol; 1996 Dec; 14(12):3133-40. PubMed ID: 8955659 [TBL] [Abstract][Full Text] [Related]
2. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer. Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592 [TBL] [Abstract][Full Text] [Related]
3. Colocalisation of matrix metalloproteinase-9-mRNA and protein in human colorectal cancer stromal cells. Zeng ZS; Guillem JG Br J Cancer; 1996 Oct; 74(8):1161-7. PubMed ID: 8883399 [TBL] [Abstract][Full Text] [Related]
4. Elevated tissue inhibitor of metalloproteinase 1 RNA in colorectal cancer stroma correlates with lymph node and distant metastases. Zeng ZS; Cohen AM; Zhang ZF; Stetler-Stevenson W; Guillem JG Clin Cancer Res; 1995 Aug; 1(8):899-906. PubMed ID: 9816060 [TBL] [Abstract][Full Text] [Related]
5. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer. Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401 [TBL] [Abstract][Full Text] [Related]
6. Matrix metalloprotease 2 (MMP-2) and matrix metalloprotease 9 (MMP-9) type IV collagenases in colorectal cancer. Liabakk NB; Talbot I; Smith RA; Wilkinson K; Balkwill F Cancer Res; 1996 Jan; 56(1):190-6. PubMed ID: 8548762 [TBL] [Abstract][Full Text] [Related]
7. Clinical relevance of the expression of mRNA of MMP-7, MMP-9, TIMP-1, TIMP-2 and CEA tissue samples from colorectal liver metastases. Sutnar A; Pesta M; Liska V; Treska V; Skalicky T; Kormunda S; Topolcan O; Cerny R; Holubec L Tumour Biol; 2007; 28(5):247-52. PubMed ID: 17992052 [TBL] [Abstract][Full Text] [Related]
8. Expression of CD147 and matrix metalloproteinase-11 in colorectal cancer and their relationship to clinicopathological features. Tian X; Ye C; Yang Y; Guan X; Dong B; Zhao M; Hao C J Transl Med; 2015 Oct; 13():337. PubMed ID: 26507719 [TBL] [Abstract][Full Text] [Related]
9. High expression of matrix metalloproteinases: MMP-2 and MMP-9 predicts poor survival outcome in colorectal carcinoma. Salem N; Kamal I; Al-Maghrabi J; Abuzenadah A; Peer-Zada AA; Qari Y; Al-Ahwal M; Al-Qahtani M; Buhmeida A Future Oncol; 2016 Feb; 12(3):323-31. PubMed ID: 26814712 [TBL] [Abstract][Full Text] [Related]
10. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes. Ries C; Loher F; Zang C; Ismair MG; Petrides PE Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746 [TBL] [Abstract][Full Text] [Related]
11. Prognostic and diagnostic implications of MMP-2, MMP-9, and VEGF-α expressions in colorectal cancer. Araújo RF; Lira GA; Vilaça JA; Guedes HG; Leitão MC; Lucena HF; Ramos CC Pathol Res Pract; 2015 Jan; 211(1):71-7. PubMed ID: 25446246 [TBL] [Abstract][Full Text] [Related]
12. Overexpression of Reg4, alone or combined with MMP-7 overexpression, is predictive of poor prognosis in colorectal cancer. Zhu X; Han Y; Yuan C; Tu W; Qiu G; Lu S; Lu H; Peng Z; Zhou C Oncol Rep; 2015 Jan; 33(1):320-8. PubMed ID: 25338725 [TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance and prognostic value of MMP-13 expression in colorectal cancer. Yang B; Gao J; Rao Z; Shen Q Scand J Clin Lab Invest; 2012 Oct; 72(6):501-5. PubMed ID: 22950625 [TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of matrix metalloproteinase-7 in colorectal cancer. Yang B; Su K; Gao J; Rao Z Asian Pac J Cancer Prev; 2012; 13(3):1049-52. PubMed ID: 22631636 [TBL] [Abstract][Full Text] [Related]
15. Association between ratio of matrix metalloproteinase-1 to tissue inhibitor of metalloproteinase-1 and local recurrence, metastasis, and survival in human chondrosarcoma. Berend KR; Toth AP; Harrelson JM; Layfield LJ; Hey LA; Scully SP J Bone Joint Surg Am; 1998 Jan; 80(1):11-7. PubMed ID: 9469303 [TBL] [Abstract][Full Text] [Related]
16. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma. Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340 [TBL] [Abstract][Full Text] [Related]
17. Role of tissue inhibitors of metalloproteinases (TIMPs) in colorectal carcinoma. Joo YE; Seo KS; Kim J; Kim HS; Rew JS; Park CS; Kim SJ J Korean Med Sci; 1999 Aug; 14(4):417-23. PubMed ID: 10485622 [TBL] [Abstract][Full Text] [Related]
18. Clinical significance of circulating tumor cells, including cancer stem-like cells, in peripheral blood for recurrence and prognosis in patients with Dukes' stage B and C colorectal cancer. Iinuma H; Watanabe T; Mimori K; Adachi M; Hayashi N; Tamura J; Matsuda K; Fukushima R; Okinaga K; Sasako M; Mori M J Clin Oncol; 2011 Apr; 29(12):1547-55. PubMed ID: 21422427 [TBL] [Abstract][Full Text] [Related]
19. Simultaneous determination of matrix metalloproteinase (MMP)-7, MMP-1, -3, and -13 gene expression by multiplex PCR in colorectal carcinomas. Roeb E; Arndt M; Jansen B; Schumpelick V; Matern S Int J Colorectal Dis; 2004 Nov; 19(6):518-24. PubMed ID: 15103490 [TBL] [Abstract][Full Text] [Related]
20. Clinical significance of microRNA-21 as a biomarker in each Dukes' stage of colorectal cancer. Fukushima Y; Iinuma H; Tsukamoto M; Matsuda K; Hashiguchi Y Oncol Rep; 2015 Feb; 33(2):573-82. PubMed ID: 25421755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]